Allied Biotech Corporation (1780.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan · ISIN TW0001780005

Price
23.20 TWD
Market cap
2.53 bn TWD
P/E (2025)
17.25
P/S (2025)
2.98
Dividend yield
5.39 %
Net margin
15.24 %
Return on equity (ROE)
10.49 %
Return on assets (ROA)
6.19 %

Allied Biotech Corporation financials

Fiscal year20242025
Revenue806.92 m TWD849.51 m TWD
Gross profit258.38 m TWD308.61 m TWD
Operating income88.12 m TWD120.39 m TWD
EBIT143.99 m TWD181.44 m TWD
Net income100.94 m TWD129.46 m TWD
Diluted EPS – continuing operations1.05 TWD1.35 TWD

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Allied Biotech Corporation

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company's products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutein, a carotenoid that provides a range of green leafed vegetables, such as spinach, kale, broccoli, and egg yolks.; and Nano Coenzyme Q10, an antioxidant, which is used in the transformation of energy in the body. It serves food, beverage, dietary supplement, and feed industries. The company was founded in 2001 and is headquartered in Taipei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.